Search for Clinical Trial Results

Anaplastic Astrocytoma - 343 Studies Found
Status | Study |
Completed |
Study Name: Antineoplaston Therapy in Treating Patients With Anaplastic Astrocytoma Condition: Anaplastic Astrocytoma Date: 1999-11-01 Interventions: Drug: Antineoplaston therapy (Atengenal + Astugenal) Adult |
Completed |
Study Name: Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Anaplastic Astrocytoma Condition: Glioblastoma Multiforme/Anaplastic Astrocytoma Date: 2009-02-10 Interventions:
|
Completed |
Study Name: Oral Tarceva Study for Recurrent/Residual Glioblastoma Multiforme and Anaplastic Astrocytoma Condition:
Date: 2006-03-09 Interventions: Drug: Erlotinib Tarceva®: Will be given at a starting dose of 150mg QD dose for the first cycle whi |
Terminated |
Study Name: Efficacy and Safety of AP 12009 in Patients With Recurrent or Refractory Anaplastic Astrocytoma or Secondary Glioblastoma Condition:
Date: 2008-09-26 Interventions:
|
Completed |
Study Name: A Phase II Trial of Sutent (Sunitinib; SU011248) for Recurrent Anaplastic Astrocytoma and Glioblastoma Condition:
Date: 2008-01-21 Interventions: Drug: Sunitinib Malate Initially, patients were started on sunitinib at a dose of 50 mg daily. If 50 mg |
Suspended |
Study Name: Repeated Super-selective Intraarterial Cerebral Infusion Of Bevacizumab Plus Carboplatin For Treatment Of Relapsed/Refractory GBM And Anaplastic Astrocytoma Condition:
Date: 2011-06-13 Interventions:
|
Recruiting |
Study Name: Study to Evaluate Eflornithine + Lomustine vs Lomustine in Recurrent Anaplastic Astrocytoma (AA) Patients Condition:
|
Completed |
Study Name: BNCT to Treat Glioma That Has Progressed Following Radiotherapy Condition:
Date: 2005-06-22 Interventions: Radiation: Bononophenylalanine (BPA)-based BNCT Boronophenylalanine is infused into a peripheral vein pr |
Recruiting |
Study Name: Immunophenotyping From Blood of Patients With Malignant Gliomas Condition:
Date: 2013-12-13 Interventions: Other: Blood sample and life quality questionnaires Blood will be drawn at distinct time points during a |
Active, not recruiting |
Study Name: Super-Selective Intraarterial Cerebral Infusion Of Temozolomide (Temodar) For Treatment Of Newly Diagnosed GBM And AA Condition:
Date: 2010-08-10 Interventions: Drug: Super-Selective Intraarterial Intracranial Infusion of Temozolomide A single dose of Intraarterial |